Analysts Have a 1.8 Recommendation on Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)

Marco Green
April 4, 2018

VRTX's profit will be $68.55 million for 150.91 P/E if the $0.27 EPS becomes a reality. After having $0.46 EPS previously, Ashland Global Holdings Inc.'s analysts see 82.61% EPS growth. The stock increased 1.04% or $0.72 during the last trading session, reaching $69.79. About 397,090 shares traded. It also reduced its holding in Constellation Brands Inc. (NYSE:ASH) has risen 15.02% since April 2, 2017 and is uptrending. It has outperformed by 10.16% the S&P500. In the last five years, the company's full-year sales growth remained over 10.30% a year on average and the company's earnings per share moved by an average rate of 1.04. Baillie Gifford & Company acquired 6,547 shares as Vertex Pharmaceuticals (VRTX)'s stock rose 6.91%. Pictet Asset Management Ltd. now owns 814,519 shares of the pharmaceutical company's stock valued at $75,872,000 after buying an additional 525,199 shares during the period. About 1.01 million shares traded. Bb Biotech Ag reported 6.23% in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX). It has outperformed by 65.04% the S&P500. The company has market cap of $41.38 billion. It operates through Specialty Ingredients, Performance Materials, and Valvoline divisions. The stock is now showing negative return of -1.88% throughout last week and witnessed bearish return of -1.84% in one month period. The firm provides products, technologies, and resources for solving formulation and product-performance challenges. Its the same as in 2017Q3. Ithaka Grp Ltd Llc invested in 56,323 shares or 1.51% of the stock.

Roystone Capital Management Lp decreased Alliance Data Systems Corp (ADS) stake by 3.27% reported in 2017Q4 SEC filing.

Wedbush Securities Inc decreased Liberty All (USA) stake by 108,554 shares to 67,341 valued at $424,000 in 2017Q4. Tower Research Limited Liability (Trc) holds 0% or 176 shares in its portfolio. Bb&T Corp holds 11,198 shares or 0.03% of its portfolio. Quantbot LP invested in 90,442 shares or 0.53% of the stock. Gemmer Asset Lc reported 133 shares. Janney Capital upgraded Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) on Wednesday, July 19 to "Buy" rating. Therefore 80% are positive. Expedia Inc. had 128 analyst reports since July 24, 2015 according to SRatingsIntel. As per Thursday, April 28, the company rating was maintained by RBC Capital Markets. The stock has "Underperform" rating by Oppenheimer on Friday, January 26. Credit Suisse maintained it with "Outperform" rating and $196 target in Tuesday, February 13 report. Vertex Pharmaceuticals presently has a consensus rating of "Buy" and a consensus target price of $183.96.

Since February 16, 2018, it had 0 buys, and 2 selling transactions for $8.14 million activity. TheStreet downgraded Ashland Global Holdings Inc. Cowen & Co maintained it with "Buy" rating and $20000 target in Tuesday, August 1 report. On Thursday, January 26 the stock rating was maintained by Stifel Nicolaus with "Buy". $965,671 worth of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) was sold by ALTSHULER DAVID.

Spark Investment Management Llc decreased its stake in Vertex Pharmaceuticals Inc (VRTX) by 32.78% based on its latest 2017Q4 regulatory filing with the SEC. Investors will often follow the current stock price relative to its 52-week high and low levels. C M Bidwell And Assocs Ltd reported 0% of its portfolio in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX). The rating was maintained by Jefferies on Thursday, July 13 with "Hold". Bank of America upgraded shares of Vertex Pharmaceuticals from a "neutral" rating to a "buy" rating and set a $180.00 target price on the stock in a report on Friday, January 5th. On Tuesday, October 4 the stock rating was upgraded by Monness Crespi & Hardt to "Buy". Robert W. Baird maintained Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) on Wednesday, September 6 with "Buy" rating. On Monday, September 25 the stock rating was maintained by Jefferies with "Buy". The stock of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) has "Hold" rating given on Thursday, October 26 by H.C. Wainwright. BTIG Research initiated it with "Buy" rating and $200.0 target in Friday, September 29 report.

Since October 12, 2017, it had 0 insider purchases, and 45 sales for $123.04 million activity.

Among 20 analysts covering Vertex Pharmaceuticals (NASDAQ:VRTX), 19 have Buy rating, 0 Sell and 1 Hold. $270,358 worth of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) was sold by Chodakewitz Jeffrey on Tuesday, January 16. SMITH IAN F also sold $330,671 worth of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) on Monday, October 16. Another trade for 2,125 shares valued at $324,976 was made by Parini Michael on Thursday, October 12. The stock increased 0.91% or $1.4199 during the last trading session, reaching $157.7299.

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) has revealed a visible change in the trend volumes of the stock market recently. New York State Common Retirement Fund increased its stake in shares of Vertex Pharmaceuticals by 3.5% in the third quarter. The pharmaceutical company reported $0.61 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $0.53 by $0.08.

Vertex Pharmaceuticals (NASDAQ:VRTX) last posted its quarterly earnings results on Wednesday, January 31st. (NASDAQ:EXPE). Thompson Siegel Walmsley Limited Liability Com holds 48,985 shares. Zeke Advsr Lc, a Pennsylvania-based fund reported 2,281 shares. Mcf Advisors Llc owns 7 shares. Bridgeway Cap Mngmt has invested 0.08% in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX). Commerzbank Aktiengesellschaft Fi holds 0.48% or 257,358 shares in its portfolio.

Clough Capital Partners L P, which manages about $5.01 billion and $1.20B US Long portfolio, decreased its stake in Bank Amer Corp (NYSE:BAC) by 482,700 shares to 2.03M shares, valued at $59.97M in 2017Q4, according to the filing. Da Davidson Co holds 23,712 shares or 0.07% of its portfolio. Highland Cap Management Ltd Liability has 0.03% invested in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX). Northwestern Mutual Wealth accumulated 326 shares or 0% of the stock. Overall, the share price is up 8.75% so far this year. Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) has risen 76.59% since April 2, 2017 and is uptrending.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Other reports by Click Lancashire

Discuss This Article

FOLLOW OUR NEWSPAPER